Apolipoprotein E4 phenotype increases non-fasting serum triglyceride concentration in infants - The STRIP study

Atherosclerosis

Volumn 152, Issue 1, 2000, Pages 135-141

  Tammi, Anne ^a   Rönnemaa, Tapani ^a   Viikari, Jorma ^a   Jokinen, Eero ^b   Lapinleimu, Helena ^a   Ehnholm, Christian ^c   Simell, Olli ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Apo E; Breast milk; Cholesterol; Infants; Triglycerides

Indexed keywords

APOLIPOPROTEIN E4; TRIACYLGLYCEROL;

ARTICLE; ATHEROSCLEROSIS; BOTTLE FEEDING; BREAST FEEDING; FEMALE; FINLAND; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BLOOD GLUCOSE; BREAST FEEDING; COMPARATIVE STUDY; FASTING; FEMALE; HUMAN; INCIDENCE; INFANT; INTERVENTION STUDIES; MALE; PHENOTYPE; REFERENCE VALUES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; TRIGLYCERIDES;

EID: 0343279042     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00436-0     Document Type: Article

References (29)

1. Mahley R.W., Innerarity T.L., Rall S.C. Jr, Weisgraber K.H. Plasma lipoproteins: apolipoprotein structure and function. J. Lipid Res. 25:1984;1277-1294.
2. Zannis V.I., Just P.W., Breslow J.L. Human apolipoprotein E subclasses are genetically determined. Am. J. Hum. Genet. 33:1981;11-24.
3. Mann W.A., Meyer N., Weber W., Rinninger H., Greten H., Beisiegel U. Apolipoprotein E and lipoprotein lipase co-ordinately enhance binding and uptake of chylomicrons by human hepatocytes. Eur. J. Clin. Invest. 25:1995;880-882.
4. Ehnholm C., Mahley R.W., Chappel D.A., Weisgraber K.H., Ludwig E., Witztum J.L. Role of apolipoprotein E in the lipolytic conversion of β-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Proc. Natl. Acad. Sci. 81:1984;5566-5570.
5. Utermann G., Pruin N., Steinmetz A. Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man. Clin. Genet. 15:1979;63-72.
6. Ehnholm C., Lukka M., Kuusi T., Nikkilä E., Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J. Lipid Res. 27:1986;227-235.
7. Lehtimäki T., Moilanen T., Viikari J., Åkerblom H.K., Ehnholm C., Rönnemaa T., et al. Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. J. Lipid Res. 31:1990;487-495.
8. Lapinleimu H., Viikari J., Rönnemaa T., Välimäki I., Tuominen J., Marniemi J., et al. Apolipoprotein E polymorphism and serum lipids in a randomized prospective trial of an infant diet with reduced saturated fat and cholesterol. Pediatrics. 98:1996;757-762.
9. Assmann G., Schmitz G., Menzel H.-J., Schulte H. Apolipoprotein E polymorphism and hyperlipidemia. Clin. Chem. 30:1984;641-643.
10. Eto M., Watanabe K., Ishii K. Reciprocal effects of apolipoprotein E alleles (ε2 and ε4) on plasma lipid levels in normolipidemic subjects. Clin. Genet. 29:1986;477-484.
11. Brenninkmeijer B.J., Stuyt P.M.J., Demacker P.N.M., Stalenhoef A.F.H., van't Laar A. Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein phenotype. J. Lipid Res. 28:1987;361-370.
12. Weintraub M.S., Eisenberg S., Breslow J.L. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J. Clin. Invest. 80:1987;1571-1577.
13. Davignon J., Gregg R.E., Sing C.H. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
14. Tiret L., de Knijff P., Menzel H.-J., Ehnholm C., Nicaud V., Havekes L.M. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations: the EARS study. Arterioscler. Thromb. 14:1994;1617-1624.
15. Valdez R., Howard B.W., Stern M.P., Haffner S.M. Apolipoprotein E polymorphism and insulin levels in a biethnic population. Diabetes Care. 18:1995;992-1000.
16. Haffner S.M., Stern M.P., Miettinen H., Robbins D., Howard B.W. Apolipoprotein E polymorphism and LDL size in a biethnic population. Arterioscler. Thromb. Vasc. Biol. 16:1996;1184-1188.
17. Srinivasan S.R., Ehnholm C., Wattigney W.A., Bao W., Berenson G.S. The relation of apolipoprotein E polymorphism to multiple cardiovascular risk in children: the Bogalusa Heart Study. Atherosclerosis. 123:1996;33-42.
18. Salah D., Bohnet K., Gueguen R., Siest G., Visvikis S. Combined effects of lipoprotein lipase and apolipoprotein E polymorphisms on lipid and lipoprotein levels in the Stanislas cohort. J. Lipid Res. 38:1997;904-912.
19. Dallongeville J., Lussier-Cacan S., Davignon J. Modulation of plasma triglyceride levels by apo E phenotype: a meta-analysis. J. Lipid Res. 33:1992;447-454.
20. Lapinleimu H., Viikari J., Jokinen E., Salo P., Routi T., Leino A., Rönnemaa T., Seppänen R., Välimäki I., Simell O. Prospective randomized trial in 1062 infants of diet low in saturated fat and cholesterol. Lancet. 345:1995;471-476.
21. Niinikoski H., Viikari J., Rönnemaa T., Lapinleimu H., Jokinen E., Salo P., Seppänen R., Leino A., Tuominen J., Välimäki I., Simell O. Prospective randomized trial of low-saturated-fat, low-cholesterol diet during the first 3 years of life. The STRIP baby project. Circulation. 94:1996;1386-1393.
22. Sorva R., Perheentupa J., Tolppanen E.-M. A novel format for a growth chart. Acta Paediatr. Scand. 73:1984;527-529.
23. Dart A., Sherrad B., Simpson H. Influence of apo E phenotype on postprandial triglyceride and glucose responses in subjects with and without coronary heart disease. Atherosclerosis. 130:1997;161-170.
24. Bergeron N., Havel R.J. Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele. J. Clin. Invest. 97:1996;65-72.
25. St Amand J., Moorjani S., Lupien P.J., Prud'homme D., Després J.-P. The relation of plasma triglyceride, apolipoprotein B, and high-density lipoprotein cholesterol to postheparin lipoprotein lipase activity is dependent on apolipoprotein E polymorphism. Metabolism. 45:1996;261-267.
26. Davies C.E., Gordon D., LaRosa J., Wood P.D.S., Halperin M. Correlations of plasma high-density lipoprotein cholesterol levels with other plasma lipid and lipoprotein concentrations. Circulation. 62:(Suppl 4):1980;24-30.
27. Freedman D.S., Srinivasan S.R., Webber L.S., Berenson G.S. Divergent levels of high density lipoprotein cholesterol and apolipoprotein A-I in children: the Bogalusa heart study. Arteriosclerosis. 4:1987;347-353.
28. Brown A.J., Roberts D.C.K. The effect of fasting triacylglyceride concentration and apolipoprotein E polymorphism on postprandial lipemia. Arterioscler. Thromb. 11:1991;1737-1744.
29. Reznik Y., Pousse P., Herrou M., Morello R., Mahoudeau J., Drosdowsky M.A., et al. Postprandial lipoprotein metabolism in normotriglyceridemic non-insulin-dependent diabetes patients: Influence of apolipoprotein E polymorphism. Metabolism. 45:1995;63-71.